Please assess the completion status of the following clinical trial:

Trial Title: Hemodynamic Instability Index: The Impact to Care With a New Predictive Indicator

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* All patients admitted to the study unit will be invited to participate in the study.~* Study subject has to stay in study unit for at least 12 hours.~Exclusion Criteria:~* Patients who were discharged from study unit earlier then 12 hours after admission.~* Patients who are or become dependent on extracorporeal membrane oxygenation (ECMO) support.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- visible HII - patient assessment (Type: EXPERIMENTAL): Clinical team from study unit will observe the Hemodynamic Instability Index created by the HIRBA 2.0 system for individual subjects randomized into HII group arm.~If the HII value will cross the threshold, indicative of hemodynamic deterioration, subject from the study arm will receive intervention: clinical assessment.

Based on this trial design, predict the completion outcome and termination type (if applicable).